Manufacturer of Controlled Substances Notice of Registration, 16235-16236 [E9-8090]

Download as PDF 16235 Federal Register / Vol. 74, No. 67 / Thursday, April 9, 2009 / Notices Drug Schedule dwashington3 on PROD1PC60 with NOTICES 3,4-Methylenedioxyamphetamine (7400). 3,4-Methylenedioxy-Nethylamphetamine (7404). 3,4Methylenedioxymethamphetamine (7405). 4-Methoxyamphetamine (7411) ... Dimethyltryptamine (7435) ........... Psilocybin (7437) .......................... Psilocyn (7438) ............................. N-Benzylpiperazine (7493) ........... Acetyldihydrocodeine (9051) ........ Dihydromorphine (9145) ............... Heroin (9200) ............................... Normorphine (9313) ..................... Pholcodine (9314) ........................ Tilidine (9750) ............................... 3-Methylfentanyl (9813) ................ Amphetamine (1100) .................... Methamphetamine (1105) ............ Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Phencyclidine (7471) .................... Phenylacetone (8501) .................. Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Benzoylecgonine (9180) ............... Ethylmorphine (9190) ................... Hydrocodone (9193) ..................... Levorphanol (9220) ...................... Meperidine (9230) ........................ Methadone (9250) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... Thebaine (9333) ........................... Oxymorphone (9652) ................... Alfentanil (9737) ........................... Sufentanil (9740) .......................... Fentanyl (9801) ............................ I I I I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II Dated: April 1, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–8088 Filed 4–8–09; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration 15:28 Apr 08, 2009 II II II II II II Jkt 217001 company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. Dated: April 1, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–8089 Filed 4–8–09; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances Notice of Registration By Notice dated November 26, 2008 and published in the Federal Register on December 5, 2008, (73 FR 74196), ISP Freetown Fine Chemicals, 238 South Main Street, Assonet, Massachusetts 02702, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Manufacturer of Controlled Substances; Notice of Registration The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances listed in schedule I or II, which fall under the authority of section 1002(a)(2)(B) of the Act (21 U.S.C. 952(a)(2)(B)) may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such comments or objections being sent via regular or express mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODL, 8701 VerDate Nov<24>2008 Morrissette Drive, Springfield, VA 22152; and must be filed no later than May 11, 2009. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d), (e) and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745), all applicants for registration to import a basic class of any controlled substances in schedule I or II are and will continue to be required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied. By Notice dated November 26, 2008 and published in the Federal Register on December 5, 2008, (73 FR 74095), GE Healthcare, 3350 North Ridge Avenue, Arlington Heights, Illinois 60004–1412, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Cocaine (9041), a basic class of controlled substance listed in schedule II. The company plans to manufacture a radioactive product used in diagnostic imaging in the diagnosis of Parkinson’s Disease and for manufacture in bulk for investigational new drug (IND) submission and clinical trials. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of GE Healthcare to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated GE Healthcare to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 Drug 2,5-Dimethoxyamphetamine (7396). Amphetamine (1100) .................... Methylphenidate (1724) ................ Phenylacetone (8501) .................. Dextropropoxyphene, bulk (nondosage forms) (9273). Schedule I II II II II The company plans to manufacture Phenylacetone to be used in the manufacture of Amphetamine for distribution to its customers. The bulk 2,5-Dimethoxyamphetamine will be used for conversion into non-controlled substances. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of ISP Freetown Fine Chemicals to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated ISP Freetown Fine Chemicals to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. § 823, E:\FR\FM\09APN1.SGM 09APN1 16236 Federal Register / Vol. 74, No. 67 / Thursday, April 9, 2009 / Notices and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: April 1, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–8090 Filed 4–8–09; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Employment And Training Administration Announcement Regarding States Triggering ‘‘On’’ to the Second-Tier of Emergency Unemployment Compensation 2008 (EUC08) AGENCY: Employment and Training Administration, Labor. ACTION: Notice. dwashington3 on PROD1PC60 with NOTICES Information for Claimants The duration of benefits payable in the EUC program, and the terms and conditions under which they are payable, are governed by Public Laws 110–252 and 110–449 and the operating instructions issued to the states by the U.S. Department of Labor. The State Workforce Agency in states beginning a high unemployment period will furnish a written notice of potential entitlement to each individual who is potentially eligible for Second-Tier EUC08 benefits. 15:28 Apr 08, 2009 Jkt 217001 Signed in Washington, DC, this 2nd day of April 2009. Douglas F. Small, Deputy Assistant Secretary, Employment and Training Administration. [FR Doc. E9–8079 Filed 4–8–09; 8:45 am] BILLING CODE 4510–FW–P NUCLEAR REGULATORY COMMISSION SUMMARY: Announcement regarding Colorado, Maryland, and Texas triggering ‘‘on’’ to the Second-Tier of Emergency Unemployment Compensation (EUC08). Public law 110–449 created a SecondTier of benefits for qualified unemployed workers claiming benefits in high unemployment states. The Department of Labor produces a trigger notice indicating which States qualify for the Second-Tier of EUC08 benefits and provides the beginning and ending dates of the Second-Tier period for each qualifying state. The trigger notice covering State eligibility for the SecondTier of the EUC08 program can be found at: https://ows.doleta.gov/unemploy/ claims_arch.asp. A new trigger notice is posted at this location each week that the program is in effect. Beginning April 12, 2009, Colorado, Maryland, and Texas are in a high unemployment period, resulting in their triggering ‘‘on’’ to the Second-Tier of the EUC08 program. VerDate Nov<24>2008 Persons who believe they may be entitled to additional benefits under the EUC08 program, or who wish to inquire about their rights under the program, should contact their State Workforce Agency. FOR FURTHER INFORMATION CONTACT: Scott Gibbons, U.S. Department of Labor, Employment and Training Administration, Office of Workforce Security, 200 Constitution Avenue, NW., Frances Perkins Building, Room S–4231, Washington, DC 20210, telephone number (202) 693–3008 (this is not a toll-free number) or by e-mail: gibbons.scott@dol.gov. [NRC–2008–0481] Agency Information Collection Activities: Submission for the Office of Management and Budget (OMB) Review; Comment Request AGENCY: U.S. Nuclear Regulatory Commission (NRC). ACTION: Notice of the OMB review of information collection and solicitation of public comment. SUMMARY: The NRC has recently submitted to OMB for review the following proposal for the collection of information under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). The NRC hereby informs potential respondents that an agency may not conduct or sponsor, and that a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The NRC published a Federal Register Notice with a 60-day comment period on this information collection on January 5, 2009. 1. Type of submission, new, revision, or extension: Extension/Revision. 2. The title of the information collection: 10 CFR part 51— ‘‘Environmental Protection Regulations for Domestic Licensing and Related Regulatory Functions.’’ 3. Current OMB approval number: 3150–0021. 4. The form number if applicable: Not applicable. 5. How often the collection is required: Upon submittal of an PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 application for a construction permit, operating license, operating license renewal, early site review, design certification review, decommissioning or termination review, or manufacturing license, or upon submittal of a petition for rulemaking. 6. Who will be required or asked to report: Licensees and applicants requesting approvals for actions proposed in accordance with the provisions of 10 CFR parts 30, 32, 33, 34, 35, 36, 39, 40, 50, 52, 54, 60, 61, 70, and 72. 7. An estimate of the number of annual responses: 23. 8. The estimated number of annual respondents: 23. 9. An estimate of the total number of hours needed annually to complete the requirement or request: 92,281. 10. Abstract: 10 CFR part 51 specifies information to be provided by applicants and licensees so that the NRC can make determinations necessary to adhere to the policies, regulations, and public laws of the United States, which are to be interpreted and administered in accordance with the policies set forth in the National Environmental Policy Act of 1969, as amended. A copy of the final supporting statement may be viewed free of charge at the NRC Public Document Room, One White Flint North, 11555 Rockville Pike, Room O–1 F21, Rockville, MD 20852. OMB clearance requests are available at the NRC worldwide Web site: https://www.nrc.gov/public-involve/ doc-comment/omb/. The document will be available on the NRC home page site for 60 days after the signature date of this notice. Comments and questions should be directed to the OMB reviewer listed below by May 11, 2009. Comments received after this date will be considered if it is practical to do so, but assurance of consideration cannot be given to comments received after this date. NRC Desk Officer, Office of Information and Regulatory Affairs (3150–0021), NEOB–10202, Office of Management and Budget, Washington, DC 20503. The NRC Clearance Officer is Gregory Trussell, (301) 415–6445. Dated at Rockville, Maryland, this 1st day of April 2009. For the Nuclear Regulatory Commission. Gregory Trussell, NRC Clearance Officer, Office of Information Services. [FR Doc. E9–8063 Filed 4–8–09; 8:45 am] BILLING CODE 7590–01–P E:\FR\FM\09APN1.SGM 09APN1

Agencies

[Federal Register Volume 74, Number 67 (Thursday, April 9, 2009)]
[Notices]
[Pages 16235-16236]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-8090]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Registration

    By Notice dated November 26, 2008 and published in the Federal 
Register on December 5, 2008, (73 FR 74196), ISP Freetown Fine 
Chemicals, 238 South Main Street, Assonet, Massachusetts 02702, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
2,5-Dimethoxyamphetamine (7396)............  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Phenylacetone (8501).......................  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
------------------------------------------------------------------------

    The company plans to manufacture Phenylacetone to be used in the 
manufacture of Amphetamine for distribution to its customers. The bulk 
2,5-Dimethoxyamphetamine will be used for conversion into non-
controlled substances.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
ISP Freetown Fine Chemicals to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated ISP Freetown Fine Chemicals to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. Sec.  823,

[[Page 16236]]

and in accordance with 21 CFR 1301.33, the above named company is 
granted registration as a bulk manufacturer of the basic classes of 
controlled substances listed.

    Dated: April 1, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-8090 Filed 4-8-09; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.